These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25169642)

  • 61. The selective serotonin reuptake inhibitor, escitalopram, enhances inhibition of prepotent responding and spatial reversal learning.
    Brown HD; Amodeo DA; Sweeney JA; Ragozzino ME
    J Psychopharmacol; 2012 Nov; 26(11):1443-55. PubMed ID: 22219222
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Selective verbal and spatial memory impairment after 5-HT1A and 5-HT2A receptor blockade in healthy volunteers pre-treated with an SSRI.
    Wingen M; Kuypers KP; Ramaekers JG
    J Psychopharmacol; 2007 Jul; 21(5):477-85. PubMed ID: 17092965
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram.
    Klein N; Sacher J; Geiss-Granadia T; Attarbaschi T; Mossaheb N; Lanzenberger R; Pötzi C; Holik A; Spindelegger C; Asenbaum S; Dudczak R; Tauscher J; Kasper S
    Psychopharmacology (Berl); 2006 Oct; 188(3):263-72. PubMed ID: 16955282
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The effect of 6-week treatment with escitalopram on CCK-4 challenge: a placebo-controlled study in CCK-4-sensitive healthy volunteers.
    Tõru I; Maron E; Raag M; Vasar V; Nutt DJ; Shlik J
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):645-52. PubMed ID: 22939006
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neuroplastic effects of a selective serotonin reuptake inhibitor in relearning and retrieval.
    Reed MB; Vanicek T; Seiger R; Klöbl M; Spurny B; Handschuh P; Ritter V; Unterholzner J; Godbersen GM; Gryglewski G; Kraus C; Winkler D; Hahn A; Lanzenberger R
    Neuroimage; 2021 Aug; 236():118039. PubMed ID: 33852940
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Symptom-network dynamics in irritable bowel syndrome with comorbid panic disorder using electronic momentary assessment: A randomized controlled trial of escitalopram vs. placebo.
    Kreiter D; Drukker M; Mujagic Z; Vork L; Rutten BPF; van Os J; Masclee AAM; Kruimel JW; Leue C
    J Psychosom Res; 2021 Feb; 141():110351. PubMed ID: 33412422
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Functional mapping of dynamic happy and fearful facial expressions in young adults with familial risk for psychosis - Oulu Brain and Mind Study.
    Pulkkinen J; Nikkinen J; Kiviniemi V; Mäki P; Miettunen J; Koivukangas J; Mukkala S; Nordström T; Barnett JH; Jones PB; Moilanen I; Murray GK; Veijola J
    Schizophr Res; 2015 May; 164(1-3):242-9. PubMed ID: 25703807
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Face of the Chameleon: The Experience of Facial Mimicry for the Mimicker and the Mimickee.
    Kulesza WM; Cisłak A; Vallacher RR; Nowak A; Czekiel M; Bedynska S
    J Soc Psychol; 2015; 155(6):590-604. PubMed ID: 25811746
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Subchronic SSRI administration reduces insula response during affective anticipation in healthy volunteers.
    Simmons AN; Arce E; Lovero KL; Stein MB; Paulus MP
    Int J Neuropsychopharmacol; 2009 Sep; 12(8):1009-20. PubMed ID: 19545475
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serotonin transporter occupancy by escitalopram and citalopram in the non-human primate brain: a [(11)C]MADAM PET study.
    Finnema SJ; Halldin C; Bang-Andersen B; Bundgaard C; Farde L
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):4159-67. PubMed ID: 25980484
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of a selective serotonin reuptake inhibitor escitalopram on the cutaneous silent period: a randomized controlled study in healthy volunteers.
    Pujia F; Serrao M; Brienza M; Vestrini E; Valente GO; Coppola G; Pierelli F
    Neurosci Lett; 2014 Apr; 566():17-20. PubMed ID: 24589881
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scale.
    Montejo AL; Deakin JF; Gaillard R; Harmer C; Meyniel F; Jabourian A; Gabriel C; Gruget C; Klinge C; MacFayden C; Milligan H; Mullings E; Goodwin G
    J Psychopharmacol; 2015 Oct; 29(10):1119-28. PubMed ID: 26268533
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Paradoxical effects of short-term antidepressant treatment in fMRI emotional processing models in volunteers with high neuroticism.
    Di Simplicio M; Norbury R; Reinecke A; Harmer CJ
    Psychol Med; 2014 Jan; 44(2):241-52. PubMed ID: 23597109
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oxytocin reduces top-down control of attention by increasing bottom-up attention allocation to social but not non-social stimuli - A randomized controlled trial.
    Xu X; Li J; Chen Z; Kendrick KM; Becker B
    Psychoneuroendocrinology; 2019 Oct; 108():62-69. PubMed ID: 31229634
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram.
    de Win MM; Habraken JB; Reneman L; van den Brink W; den Heeten GJ; Booij J
    Neuropsychopharmacology; 2005 May; 30(5):996-1005. PubMed ID: 15770240
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of escitalopram versus placebo on GRα messenger RNA expression in peripheral blood cells of healthy individuals with a family history of depression - a secondary outcome analysis from the randomized AGENDA trial.
    Knorr U; Koefoed P; Gluud C; Wetterslev J; Winkel P; Gether U; Vinberg M; Kessing LV
    Nord J Psychiatry; 2016; 70(4):297-302. PubMed ID: 26752119
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Preliminary evidence that sub-chronic citalopram triggers the re-evaluation of value in intimate partnerships.
    Bilderbeck AC; Wakeley J; Godlewska BR; McGlone F; Harris T; Cowen PJ; Rogers RD
    Soc Cogn Affect Neurosci; 2014 Sep; 9(9):1419-25. PubMed ID: 23996287
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients.
    Burke WJ; Gergel I; Bose A
    J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effect of a single dose of citalopram on amygdala response to emotional faces.
    Murphy SE; Norbury R; O'Sullivan U; Cowen PJ; Harmer CJ
    Br J Psychiatry; 2009 Jun; 194(6):535-40. PubMed ID: 19478294
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
    Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
    Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.